SCHEMBL1614653

SCHEMBL1614653

COc1cc(-c2cc(=O)n3nc(C)c(-c4cccc5ccccc45)c3[nH]2)cc(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 6/20 0.48
PARP1 P09874 2/20 0.44
PLAT P00750 2/20 0.42
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
TSHR P16473 1/20 0.37
MAPT P10636 1/20 0.37
KIT P10721 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279133 0.87 PDGFRB (0.45) PDGFRBPARP1LMNASMN1; SMN2PTGES
SCHEMBL1613592 0.86 KDM4E (0.43) PARP1PLATLMNASMN1; SMN2KMT2A
SCHEMBL1614570 0.86 ADORA2A (0.40) LMNASMN1; SMN2KMT2AKDM4EHSD17B10
SCHEMBL1614781 0.85 PARP1 (0.44) PDGFRBPARP1PLATLMNASMN1; SMN2
SCHEMBL1614156 0.82 KMT2A (0.39) PARP1SMN1; SMN2KMT2AKDM4EHSD17B10
SCHEMBL1614119 0.79 DHFR (0.40) PLATSMN1; SMN2KDM4E
SCHEMBL19084584 0.79 PSD (0.54) PARP1LMNASMN1; SMN2KMT2AKDM4E
SCHEMBL1613743 0.78 SMN1; SMN2 (0.47) PARP1PLATLMNASMN1; SMN2KMT2A
SCHEMBL1614608 0.78 PSD (0.47) SMN1; SMN2KMT2APOLBMAPT
SCHEMBL1614238 0.78 KCNQ3 (0.38) PLATKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PDGFRB 1475/4885PARP1 640/4885PLAT 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.